Sex-specific life course changesin the neuro-metabolic phenotype of glut3 null heterozygous mice: Ketogenic diet ameliorates electroencephalographic seizures and improves sociability

Endocrinology

Volumn 158, Issue 4, 2017, Pages 936-949

  Dai, Yun ^a   Zhao, Yuanzi ^a   Tomi, Masatoshi ^a   Shin, Bo Chul ^a   Thamotharan, Shanthie ^a   Mazarati, Andrey ^b   Sankar, Raman ^b   Wang, Elizabeth A ^b   Cepeda, Carlos ^b   Levine, Michael S ^b   Zhang, Jingjing ^b   Frew, Andrew ^b   Alger, Jeffry R ^b   Clark, Peter M ^b   Sondhi, Monica ^a   Kositamongkol, Sudatip ^a   Leibovitch, Leah ^a   Devaskar, Sherin U ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN[1-40]; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 2; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; NLGN4 PROTEIN, MOUSE;

AGING; ANIMAL EXPERIMENT; ARTICLE; AUTISM; BRAIN METABOLISM; CEREBROSPINAL FLUID; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; HIPPOCAMPUS; HYPOGLYCEMIA; KETOGENIC DIET; MALE; MEMORY; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; SEX DIFFERENCE; SPATIAL LEARNING; VOCALIZATION; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DIET THERAPY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEX FACTOR; SOCIAL BEHAVIOR;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL ADHESION MOLECULES, NEURONAL; DIET, KETOGENIC; ELECTROENCEPHALOGRAPHY; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 3; MALE; MEMORY; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SEIZURES; SEX FACTORS; SOCIAL BEHAVIOR; SPATIAL LEARNING; VOCALIZATION, ANIMAL;

EID: 85016775423     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1816     Document Type: Article

References (47)

1. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: The role of nutrient transporters. J Cereb Blood Flow Metab. 2007;27(11):1766-1791.
2. Devaskar S, Zahm DS, Holtzclaw L, Chundu K, Wadzinski BE. Developmental regulation of the distribution of rat brain insulininsensitive (Glut 1) glucose transporter. Endocrinology. 1991; 129(3):1530-1540.
3. Mantych GJ, James DE, Chung HD, Devaskar SU. Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain. Endocrinology. 1992;131(3):1270-1278.
4. Sankar R, Thamotharan S, Shin D, Moley KH, Devaskar SU. Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain. Brain Res Mol Brain Res. 2002;107(2):157-165.
5. Shin BC, McKnight RA, Devaskar SU. Glucose transporter GLUT8 translocation in neurons is not insulin responsive. J Neurosci Res. 2004;75(6):835-844.
6. Stuart CA, Ross IR, Howell ME, McCurryMP, Wood TG, Ceci JD, Kennel SJ, Wall J. Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. Brain Res. 2011;1384:15-22.
7. Ganguly A, McKnight RA, Raychaudhuri S, Shin BC, MaZ, Moley K, Devaskar SU. Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. Am J Physiol Endocrinol Metab. 2007;292(5):E1241-E1255.
8. Zhao Y, Fung C, Shin D, Shin BC, Thamotharan S, Sankar R, Ehninger D, Silva A, Devaskar SU. Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders. Mol Psychiatry. 2010;15(3):286-299.
9. Fung C, Evans E, Shin D, Shin BC, Zhao Y, Sankar R, Chaudhuri G, Devaskar SU. Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice. J Neurosci Res. 2010; 88(15):3386-3398.
10. Taschereau RV, Chatziioannou NT. Calibration and data standardization of a prototype bench-top pre-clinical CT. In: A.F. Institute of Electrical and Electronics Engineers Nuclear Science Symposium & Medical Imaging Conference; November 8-15, 2014; Seattle, WA.
11. Loening AM, Gambhir SS. AMIDE: A free software tool for multimodality medical image analysis. Mol Imaging. 2003;2(3): 131-137.
12. Zovein A, Flowers-Ziegler J, Thamotharan S, Shin D, Sankar R, Nguyen K, Gambhir S, Devaskar SU. Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol. 2004;286(2): R273-R282.
13. Ganguly A, Devaskar SU. Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance. Am J Physiol Endocrinol Metab. 2008;294(6): E1144-E1151.
14. State MW. The genetics of child psychiatric disorders: Focus on autism and Tourette syndrome. Neuron. 2010;68(2):254-269.
15. Shin BC, Dai Y, Thamotharan M, Gibson LC, Devaskar SU. Preand postnatal calorie restriction perturbs early hypothalamic neuropeptide and energy balance. J Neurosci Res. 2012;90(6): 1169-1182.
16. Cummings DM, André VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci. 2009; 29(33):10371-10386.
17. Tomi M, Zhao Y, Thamotharan S, Shin BC, Devaskar SU. Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging. Brain Res. 2013;1495:61-75.
18. Shin BC, Suzuki M, Inukai K, Anai M, Asano T, Takata K. Multiple isoforms of the regulatory subunit for phosphatidylinositol 3-kinase (PI3-kinase) are expressed in neurons in the rat brain. Biochem Biophys Res Commun. 1998;246(2):313-319.
19. Klepper J, Leiendecker B. GLUT1 deficiency syndrome-2007 update. Dev Med Child Neurol. 2007;49(9):707-716.
20. De Vivo DC, Leary L, Wang D. Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 2002;17(Suppl 3):3S15-3S25.
21. Wang D, Pascual JM, Yang H, Engelstad K, MaoX, Cheng J, Yoo J, Noebels JL, De Vivo DC. A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet. 2006;15(7):1169-1179.
22. Benedict C, Kern W, Schultes B, Born J, Hallschmid M. Differential sensitivity of men and women to anorexigenic and memoryimproving effects of intranasal insulin. J Clin Endocrinol Metab. 2008;93(4):1339-1344.
23. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin [published correction appears in Diabetes. 2007;56(10):2649]. Diabetes. 2006; 55(4):978-987.
24. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes. 2003;52(3):682-687.
25. Hami J, Sadr-Nabavi A, Sankian M, Haghir H. Sex differences and left-right asymmetries in expression of insulin and insulin-like growth factor-1 receptors in developing rat hippocampus. Brain Struct Funct. 2012;217(2):293-302.
26. Haghir H, Rezaee AA, Nomani H, Sankian M, Kheradmand H, Hami J. Sexual dimorphism in expression of insulin and insulin-like growth factor-I receptors in developing rat cerebellum. Cell Mol Neurobiol. 2013;33(3):369-377.
27. Xu WH, Huber R, Riepe MW. Gender- and region-specific expression of insulin receptor protein in mouse brain: Effect of mild inhibition of oxidative phosphorylation. J Neural Transm (Vienna). 2007;114(3):373-377.
28. Vavaiya KV, Paranjape SA, Briski K.P. Testicular regulation of neuronal glucose and monocarboxylate transporter gene expression profiles in CNS metabolic sensing sites during acute and recurrent insulin-induced hypoglycemia. J Mol Neurosci. 2007;31(1): 37-46.
29. Molina PE, Abumrad NN. Contribution of excitatory amino acids to hypoglycemic counter-regulation. Brain Res. 2001;899(1-2): 201-208.
30. Cranston I, Reed LJ, Marsden PK, Amiel SA. Changes in regional brain (18)F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes. 2001;50(10):2329-2336.
31. Boyle PJ. Alteration in brain glucose metabolism induced by hypoglycaemia in man. Diabetologia. 1997;40(Suppl 2):S69-S74.
32. Weisová P, Concannon CG, Devocelle M, Prehn JH, Ward MW. Regulation of glucose transporter 3 surface expression by the AMPactivated protein kinase mediates tolerance to glutamate excitation in neurons. J Neurosci. 2009;29(9):2997-3008.
33. Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, Mukaddes NM, Balkhy S, Gascon G, Hashmi A, Al-Saad S, Ware J, Joseph RM, Greenblatt R, Gleason D, Ertelt JA, Apse KA, Bodell A, Partlow JN, Barry B, Yao H, Markianos K, Ferland RJ, Greenberg ME, Walsh CA. Identifying autism loci and genes by tracing recent shared ancestry. Science. 2008;321(5886):218-223.
34. Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol. 2007;17(4):434-447.
35. Rubenstein JL. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol. 2010;23(2):118-123.
36. Bottos A, Rissone A, Bussolino F, Arese M. Neurexins and neuroligins: Synapses look out of the nervous system. Cell Mol Life Sci. 2011;68(16):2655-2666.
37. Krueger DD, Tuffy LP, Papadopoulos T, Brose N. The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Curr Opin Neurobiol. 2012;22(3): 412-422.
38. Peça J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011; 472(7344):437-442.
39. Schütt J, Falley K, Richter D, Kreienkamp HJ, Kindler S. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. J Biol Chem. 2009;284(38):25479-25487.
40. Takeda S, Sato N, Niisato K, Takeuchi D, Kurinami H, Shinohara M, Rakugi H, Kano M, Morishita R. Validation of abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Res. 2009;1280:137-147.
41. Piermartiri TC, Figueiredo CP, Rial D, Duarte FS, Bezerra SC, Mancini G, de Bem AF, Prediger RD, Tasca CI. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-b(1-40) administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage. Exp Neurol. 2010;226(2):274-284.
42. Prediger RD, Medeiros R, Pandolfo P, Duarte FS, Passos GF, Pesquero JB, Campos MM, Calixto JB, Takahashi RN. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience. 2008;151(3):631-643.
43. Coman DJ, Sinclair KG, Burke CJ, Appleton DB, Pelekanos JT, O'Neil CM, Wallace GB, Bowling FG, Wang D, De Vivo DC, McGill JJ. Seizures, ataxia, developmental delay and the general paediatrician: Glucose transporter 1 deficiency syndrome. J Paediatr Child Health. 2006;42(5):263-267.
44. Verrotti A, D'Egidio C, Agostinelli S, Gobbi G. Glut1 deficiency: when to suspect andhowto diagnose? Eur J Paediatr Neurol. 2012;16(1):3-9.
45. Roeske D, Ludwig KU, Neuhoff N, Becker J, Bartling J, Bruder J, Brockschmidt FF, Warnke A, RemschmidtH, Hoffmann P, Müller-Myhsok B, Nöthen MM, Schulte-Körne G. First genome-wide association scan on neurophysiological endophenotypes points to trans-regulation effects on SLC2A3 in dyslexic children. Mol Psychiatry. 2011;16(1):97-107.
46. Mlynarski EE, Sheridan MB, Xie M, Guo T, Racedo SE, McDonald-McGinn DM, Gai X, Chow EW, Vorstman J, Swillen A, Devriendt K, Breckpot J, Digilio MC, Marino B, Dallapiccola B, Philip N, Simon TJ, Roberts AE, Piotrowicz M, Bearden CE, Eliez S, Gothelf D, Coleman K, Kates WR, Devoto M, Zackai E, Heine-Suñer D, Shaikh TH, Bassett AS, Goldmuntz E, Morrow BE, Emanuel BS; International Chromosome 22q11.2 Consortium. Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome. Am J Hum Genet. 2015;96(5):753-764.
47. Lesch KP, Selch S, Renner TJ, Jacob C, Nguyen TT, Hahn T, Romanos M, Walitza S, Shoichet S, Dempfle A, Heine M, Boreatti-Hümmer A, Romanos J, Gross-Lesch S, Zerlaut H, Wultsch T, Heinzel S, Fassnacht M, Fallgatter A, Allolio B, Schäfer H, Warnke A, Reif A, Ropers HH, Ullmann R. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: Association with neuropeptideY gene dosage in an extended pedigree. Mol Psychiatry. 2011;16(5):491-503.